Skip to main content
4SC AG logo

4SC AG — Investor Relations & Filings

Ticker · VSC ISIN · DE000A3E5C40 LEI · 391200QOKN7LGVP0RQ86 F Manufacturing
Open in API
Filings indexed 719 across all filing types
Latest filing 2011-02-24 Share Issue/Capital Cha…
Country DE Germany
Listing F VSC

About 4SC AG

https://www.4sc.com/

4SC AG is a biopharmaceutical company that formerly focused on the research and development of small-molecule drugs for cancer treatment. The company's strategy centered on addressing diseases with high unmet medical needs by developing innovative therapies that targeted epigenetic mechanisms of action. According to the company's official statements, it currently has no products under development and no operational business.

Recent filings

Filing Released Lang Actions
4SC Completes Capital Increase
Share Issue/Capital Change Classification · 99% confidence The document is titled 'News Details' and is disseminated as an 'Ad-hoc' announcement on February 24, 2011. The core content describes the completion of a capital increase, where 4SC AG raised EUR 11.74 million by placing new shares and increasing the total number of issued shares. This action directly relates to the company's capital structure and fundraising activities. This aligns perfectly with the definition for 'Capital/Financing Update' (CAP). Although it is an announcement, it is a specific corporate action announcement, not a general announcement about the publication of a separate report (which would be RPA or RNS).
2011-02-24 English
4SC Announces Capital Increase
Share Issue/Capital Change Classification · 98% confidence The document is titled '4SC Announces Capital Increase' and explicitly details a decision by the management board, with supervisory board consent, to increase the company's share capital by issuing new shares via an accelerated book-building process, excluding existing shareholder subscription rights. This action directly relates to changes in the company's capital structure and fundraising activities. This aligns perfectly with the definition for 'Capital/Financing Update' (CAP). Although it is an Ad-hoc announcement, the core subject matter is capital change, making CAP more specific than the general 'RNS' fallback.
2011-02-23 English
Report Publication Announcement 2011
Report Publication Announcement Classification · 100% confidence The document is a short announcement dated February 7, 2011, from 4SC AG. The title explicitly states it is an "Announcement according to Articles 37v, 37w, 37x et seqq. of the WpHG with the objective of Europe-wide distribution" and specifically mentions "Preliminary announcement on the disclosure of financial statements." The body of the text lists several future reports (Annual financial report, Financial report (half-year), Quarterly financial reports) along with their planned disclosure dates and links. According to Rule #2 (The 'MENU VS MEAL' Rule), a short document whose primary purpose is to announce the future publication or availability of other reports should be classified as a Report Publication Announcement (RPA).
2011-02-07 English
Hinweis auf Quartalsfinanzbericht
Report Publication Announcement Classification · 100% confidence The document is a short notification (712 characters) announcing the availability of a quarterly financial report. It provides a link to the website where the report can be found rather than containing the report itself. Following the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA).
2011-02-07 German
Datum:07.02.2011
Report Publication Announcement Classification · 100% confidence The document is a short notification (697 characters) announcing the availability of a quarterly financial report ('Quartalsfinanzbericht') for 4SC AG. It provides a link to the company's website where the report can be accessed rather than containing the report itself. Following the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA).
2011-02-07 German
4SC Presents Update on Phase II SHELTER trial with Oral Pan-HDAC Resminostat at the 2011 Gastrointestinal Cancer Symposium
Regulatory Filings Classification · 100% confidence The document is a press release dated January 21, 2011, announcing that 4SC AG will present a poster update on its Phase II SHELTER trial at the 2011 Gastrointestinal Cancer Symposium. It details the abstract, presenter, and provides background information on the drug (Resminostat) and the company. This type of announcement, detailing participation in a scientific conference or providing preliminary clinical data updates outside of a formal quarterly/annual filing, is best classified as a general corporate announcement or regulatory filing that doesn't fit the specific financial report categories (10-K, IR, ER). Since it is a specific, non-standard corporate update disseminated via a news service (DGAP), and it is not a formal financial report, a management discussion, or a proxy statement, the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements.
2011-01-21 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.